Research and experimental development on natural sciences and engineering
PHARMA HOLDINGS AS
Revenue 2024
NOK 120,000
Operating profit
NOK −17.8m
Equity
NOK 8.2m
Incorporated
2016
Employees
5
Share capital
NOK 1.4m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 120k | |
| Total operating costs | 17.9m | |
| Operating profit (EBIT) | −17.8m | |
| Net financial items | 198k | |
| Profit for the year | −17.6m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 9.5m | |
| of which current assets | 3.0m | |
| Equity | 8.2m | |
| Total liabilities | 1.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.